+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07644585

Pilot Study Evaluating Ultra-High Dose Rate ConformalFLASH Proton Therapy for Reirradiation in Head and Neck Cancer Patients Not Eligible for Surgery

Led by IBA Proton Therapy, Inc. · Updated on 2026-09-18

10

Participants Needed

1

Research Sites

261 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the feasibility of ultra-high dose-rate conformal proton therapy ConformalFLASH for patients with head and neck cancer who need re-irradiation but cannot have surgery. This pilot study compares ConformalFLASH treatment planning and delivery to conventional Stereotactic Body Radiation Therapy SBRT, a standard re-irradiation approach. The study aims to explore if ultra-high dose rates can reduce normal tissue damage while maintaining tumor control. Participants will receive ConformalFLASH irradiation using pencil-beam scanning proton therapy without chemotherapy. Treatment involves five fractions of 8 GyRBE each, delivered over approximately 1.5 to 2 weeks. The planning and delivery process follows SBRT workflows, focusing on dose rates of at least 40 GyRBE per second. This investigational treatment is designed for patients who have previously had significant radiation to the head and neck. During the study, participants will undergo treatment delivery and monitoring for acute toxicities up to three months after starting treatment. Researchers will also evaluate treatment accuracy, late toxicities, tumor control at 3 months and 1 year, survival, and patient quality of life over up to 5 years. Participants provide informed consent and are followed closely to assess outcomes and safety throughout the study period.

CONDITIONS

Brief Title

A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck

Research Team

S

Sophie Le Bail

S

Sofie Gillis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here